Statutes Authorizing the Agency to Adopt Rules on this Subject: RCW 41.05.021, 41.05.160, 43.71C.110, and ESSHB [E2SHB] 1224, chapter 334, Laws of 2019.

Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: The health care authority (HCA) is revising this section to include chapter 182-70 WAC, All payer health care claims database; and new chapter 182-51 WAC, Washington prescription drug pricing transparency program, as chapters that this section applies to. New rules for the Washington prescription drug pricing transparency program are being promulgated under WSR 20-03-078. HCA also intends to clarify in this section that rules in chapter 182-526 WAC do not apply to the school benefits board found in chapter 182-32 WAC. During the course of this review, the agency may identify additional related changes that are required in order to improve clarity or update policy.

Process for Developing New Rule: The agency welcomes the public to take part in developing this rule. If interested, contact the person identified below to receive an early rule draft to review. After the early review, the agency will send a notice of proposed rule making (CR-102) to everyone receiving this notice and anyone who requests a copy.

Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Jason Crabbe (Rulemaking Questions), P.O. Box 42716, Olympia, WA 98504-2716, phone 360-725-9563, fax 360-586-9727, telecommunication[s] relay services (TRS) 711, email jason.crabbe@hca.wa.gov, website www.hca.wa.gov/about-hca/rulemaking; or Kerry Breen (Program Questions), P.O. Box 42700, Olympia, WA 98504-2700, phone 360-725-9970, fax 360-586-9727, TRS 711, email kerry.breen@hca.wa.gov, website www.hca.wa.gov/about-hca/rulemaking.